Phase 2 Lung Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with stage IV non-small cell lung cancer (a type of lung cancer), or lung cancer that has come back and cannot be removed with surgery.
- People who have not yet received any systemic (whole-body) treatment, such as chemotherapy, for their advanced or spread lung cancer.
- People who are able to provide a tissue sample from their tumour (either a recent or stored sample taken within 5 months of joining the trial), which the trial site must submit.
- People who are relatively well and able to carry out daily activities, as measured by a standard medical scale (a score of 0 or 1 on the ECOG scale, meaning fully active or restricted in strenuous activity only).
- People whose cancer can be measured on scans using standard medical criteria.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose cancer has a specific known genetic change for which an approved targeted treatment already exists as a first-line option.
- People who have previously been treated with immunotherapy (treatments that work by stimulating the immune system to fight cancer).
- People who have cancer that has spread to the brain or spinal cord and has not yet been treated.
- There may be additional criteria not listed here that the trial site will assess (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
5 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Objective response rate (ORR) by investigator (per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.